D L Carlson Investment Group Inc. Sells 24,718 Shares of Colgate-Palmolive Company $CL

Key Points

• D L Carlson Investment Group Inc. reduced its stake in Colgate-Palmolive by 66.3% during the 1st quarter, selling 24,718 shares and holding a total of 12,576 shares worth approximately $1,178,000.
• Colgate-Palmolive reported $5.11 billion in revenue for the recent quarter, exceeding analysts' expectations, and posted an earnings per share (EPS) of $0.92.
• The company declared a quarterly dividend of $0.52 per share, representing a yield of 2.5%, with a dividend payout ratio of 58.43%.

D L Carlson Investment Group Inc. lessened its stake in shares of Colgate-Palmolive Company (NYSE:CL - Free Report) by 66.3% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 12,576 shares of the company's stock after selling 24,718 shares during the quarter. D L Carlson Investment Group Inc.'s holdings in Colgate-Palmolive were worth $1,178,000 as of its most recent filing with the SEC.

Several other large investors also recently made changes to their positions in CL. Westend Capital Management LLC boosted its stake in shares of Colgate-Palmolive by 111.1% during the 1st quarter. Westend Capital Management LLC now owns 266 shares of the company's stock worth $25,000 after acquiring an additional 140 shares in the last quarter. Cornerstone Planning Group LLC boosted its stake in shares of Colgate-Palmolive by 1,913.3% during the 1st quarter. Cornerstone Planning Group LLC now owns 302 shares of the company's stock worth $28,000 after acquiring an additional 287 shares in the last quarter. Vermillion Wealth Management Inc. bought a new stake in shares of Colgate-Palmolive during the 4th quarter worth about $31,000. Accredited Wealth Management LLC bought a new stake in shares of Colgate-Palmolive during the 4th quarter worth about $34,000. Finally, Bernard Wealth Management Corp. bought a new stake in shares of Colgate-Palmolive during the 4th quarter worth about $36,000. Institutional investors own 80.41% of the company's stock.

Colgate-Palmolive Trading Up 0.2%

Colgate-Palmolive stock opened at $84.21 on Wednesday. The business has a 50 day moving average price of $87.39 and a two-hundred day moving average price of $89.90. The company has a quick ratio of 0.57, a current ratio of 0.89 and a debt-to-equity ratio of 6.79. The stock has a market cap of $68.06 billion, a price-to-earnings ratio of 23.66, a price-to-earnings-growth ratio of 4.37 and a beta of 0.35. Colgate-Palmolive Company has a 12 month low of $82.40 and a 12 month high of $109.30.

Colgate-Palmolive (NYSE:CL - Get Free Report) last issued its earnings results on Friday, August 1st. The company reported $0.92 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.89 by $0.03. Colgate-Palmolive had a return on equity of 377.63% and a net margin of 14.55%.The business had revenue of $5.11 billion during the quarter, compared to analysts' expectations of $5.03 billion. During the same period in the prior year, the firm posted $0.91 EPS. Colgate-Palmolive's quarterly revenue was up 1.0% compared to the same quarter last year. As a group, equities analysts forecast that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, August 15th. Stockholders of record on Friday, July 18th were issued a $0.52 dividend. The ex-dividend date of this dividend was Friday, July 18th. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.5%. Colgate-Palmolive's dividend payout ratio is presently 58.43%.

Analyst Upgrades and Downgrades

Several analysts recently weighed in on the company. Citigroup decreased their target price on Colgate-Palmolive from $108.00 to $105.00 and set a "buy" rating for the company in a research note on Monday, August 4th. UBS Group decreased their target price on Colgate-Palmolive from $109.00 to $106.00 and set a "buy" rating for the company in a research note on Thursday, July 17th. Wells Fargo & Company decreased their target price on Colgate-Palmolive from $88.00 to $83.00 and set an "underweight" rating for the company in a research note on Monday, August 4th. Barclays increased their target price on Colgate-Palmolive from $86.00 to $87.00 and gave the company an "equal weight" rating in a research note on Tuesday, July 15th. Finally, JPMorgan Chase & Co. decreased their target price on Colgate-Palmolive from $99.00 to $95.00 and set an "overweight" rating for the company in a research note on Monday, August 4th. Seven research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $98.92.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.